2016 Q4 Sentiment Chemed Corp (NYSE:CHE)

July 17, 2017 - By Michael Collier

  2016 Q4 Sentiment Chemed Corp (NYSE:CHE)

Sentiment for Chemed Corp (NYSE:CHE)

Chemed Corp (NYSE:CHE) institutional sentiment increased to 1.05 in Q4 2016. Its up 0.23, from 0.82 in 2016Q3. The ratio increased, as 105 institutional investors opened new and increased equity positions, while 100 sold and reduced their equity positions in Chemed Corp. The institutional investors in our partner’s database reported: 16.12 million shares, up from 15.54 million shares in 2016Q3. Also, the number of institutional investors holding Chemed Corp in their top 10 equity positions increased from 1 to 2 for an increase of 1. Sold All: 19 Reduced: 81 Increased: 74 New Position: 31.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The company has market cap of $3.38 billion. The Firm operates through two divisions: the VITAS segment and the Roto-Rooter segment (Roto-Rooter). It has a 30.24 P/E ratio. The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

About 61,643 shares traded. Chemed Corporation (NYSE:CHE) has risen 54.48% since July 17, 2016 and is uptrending. It has outperformed by 37.78% the S&P500.

Wall Street await Chemed Corporation (NYSE:CHE) to release earnings on July, 24. Analysts forecast earnings per share of $1.88, up exactly $0.17 or 9.94 % from 2014’s $1.71 EPS. The expected CHE’s profit could reach $30.84 million giving the stock 27.40 P/E in the case that $1.88 earnings per share is reported. After posting $1.82 EPS for the previous quarter, Chemed Corporation’s analysts now forecast 3.30 % EPS growth.

Van Berkom & Associates Inc. holds 3% of its portfolio in Chemed Corporation for 465,276 shares. Riverbridge Partners Llc owns 764,047 shares or 2.56% of their US portfolio. Moreover, Cardinal Capital Management Llc Ct has 1.59% invested in the company for 231,137 shares. The Pennsylvania-based Copeland Capital Management Llc has invested 1.4% in the stock. Eagle Boston Investment Management Inc, a Massachusetts-based fund reported 64,004 shares.#img1#

Since January 1, 0001, it had 1 buy, and 5 selling transactions for $3.81 million activity.

Chemed Corporation (NYSE:CHE) Ratings Coverage

Ratings analysis reveals 50% of Chemed’s analysts are positive. Out of 2 Wall Street analysts rating Chemed, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $129 while the high is $20800. The stock’s average target of $176.50 is -14.34% below today’s ($206.04) share price. CHE was included in 9 notes of analysts from July 27, 2015. The firm has “Hold” rating by RBC Capital Markets given on Wednesday, July 5. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) rating on Monday, May 2. RBC Capital Markets has “Sector Perform” rating and $136 target. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, October 26. The firm has “Outperform” rating by Oppenheimer given on Monday, October 26. The stock of Chemed Corporation (NYSE:CHE) earned “Sector Perform” rating by RBC Capital Markets on Monday, July 27. RBC Capital Markets maintained the shares of CHE in report on Tuesday, May 30 with “Hold” rating. As per Tuesday, September 22, the company rating was maintained by Oppenheimer. The rating was maintained by RBC Capital Markets with “Sector Perform” on Tuesday, November 1.

More notable recent Chemed Corporation (NYSE:CHE) news were published by: Seekingalpha.com which released: “Chemed: Hospice And…Plumbing?” on April 04, 2017, also Seekingalpha.com with their article: “Chemed’s (CHE) CEO Kevin McNamara on Q4 2016 Results – Earnings Call Transcript” published on February 16, 2017, Seekingalpha.com published: “Chemed’s (CHE) CEO Kevin McNamara on Q1 2017 Results – Earnings Call Transcript” on April 27, 2017. More interesting news about Chemed Corporation (NYSE:CHE) were released by: Seekingalpha.com and their article: “Chemed: Finally Time For That Roto-Rooter Spin-Off” published on November 24, 2016 as well as Businesswire.com‘s news article titled: “Chemed To Report Second-Quarter 2017 Earnings July 25, Related Conference Call …” with publication date: July 10, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.